JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 11 April 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.02538-06v1
81/12/6276    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chevalier, S. A.
Right arrow Articles by Mahieux, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chevalier, S. A.
Right arrow Articles by Mahieux, R.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.02538-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Construction and characterization of a full length infectious Simian T-cell Lymphotropic Virus Type-3 molecular clone

Sébastien Alain Chevalier, Marine Walic, Sara Calattini, Adeline Mallet, Marie-Christine Prévost, Antoine Gessain, and Renaud Mahieux*

Unité d'Epidémiologie et Physiopathologie des Virus Oncogènes, CNRS URA 3015, Département de Virologie, Institut Pasteur, 28 rue du Dr Roux, 75015 Paris, France; Plateforme de Microscopie Electronique, Institut Pasteur, 25 rue du Dr Roux, 75015 Paris, France

* To whom correspondence should be addressed. Email: rmahieux{at}pasteur.fr.


   Abstract

Together with their simian STLV equivalent, HTLV-1, HTLV-2 and HTLV-3 form the Primate T Lymphotropic virus (PTLV) group. Over years, understanding the HTLV-1 and HTLV-2 biology and their pathogenesis has been widely improved by the creation of molecular clones. On the contrary, so far, PTLV-3 experimental studies have been restricted to overexpression of tax gene using reporter assays. We have therefore decided to construct an STLV-3 molecular clone. We generated a full length STLV-3 proviral clone (8891 bp) by PCR amplification of overlapping fragments. This STLV-3 molecular clone was then transfected into 293T cells. RT-PCR experiments followed by sequence analysis of the amplified products allowed us to establish that both gag and tax/rex mRNAs were transcribed. Western-blot further demonstrated the presence of the STLV-3 p24gag protein in the cell culture supernatant from transfected cells. Transient transfection of 293T and of 293T-LTR-GFP cells with the STLV-3 clone promoted syncytia formation, a hallmark of PTLV Env expression, together with the appearance of fluorescent cells, also demonstrating that the Tax-3 protein is expressed. Virus particles were visible by electron microscopy. These particles are infectious, as demonstrated by our cell-free infection experiments with purified virions. Altogether, our data demonstrate that the STLV-3 molecular clone is functional and infectious. This clone will give us a unique opportunity to study in vitro the different pX transcripts, the putative presence of antisense transcripts and to evaluate the PTLV-3 pathogenicity in vivo.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.